Working… Menu

Capecitabine and Oxaliplatin Plus Bevacizumab as Neoadjuvant Treatment for Untreated Unresectable Liver-only Metastases From Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01022541
Recruitment Status : Completed
First Posted : December 1, 2009
Last Update Posted : November 25, 2015
Roche Pharma AG
Information provided by (Responsible Party):
Royal Marsden NHS Foundation Trust